Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[18F]TZ4877: sourced facts only. name: "This study aimed to use the sphingosine 1-phosphate receptor 1 (S1PR1) targeted tracer [18F]TZ4877 with PET/CT to assess synovial inflammation in a collagen-induced arthritis (CIA) mouse model." [PMID:40923515]; target: "This study aimed to use the sphingosine 1-phosphate receptor 1 (S1PR1) targeted tracer [18F]TZ4877 with PET/CT to assess synovial inflammation in a collagen-induced arthritis (CIA) mouse model." [PMID:40923515]; developer: "Department of Rheumatology, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China." [PMID:40923515]; modality: "The radiotracer holds promise as a noninvasive tool for the quantitative diagnosis of RA." [PMID:40923515]; stage: "In PET/CT imaging of RA, [18F]TZ4877 can be used to detect the expression of S1PR1 effectively in CIA mouse models." [PMID:40923515]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [18F]TZ4877.